Illumina [ILMN] vs Iqvia Holdings [IQV] Detailed Stock Comparison
Illumina
NASDAQ
Loading...
Iqvia Holdings
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Illumina wins in 9 metrics, Iqvia Holdings wins in 10 metrics, with 0 ties. Iqvia Holdings appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Illumina | Iqvia Holdings | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 12.57 | 27.70 | Illumina |
| Price-to-Book Ratio | 6.77 | 5.62 | Iqvia Holdings |
| Debt-to-Equity Ratio | 115.06 | 272.12 | Illumina |
| PEG Ratio | -0.11 | -1.25 | Iqvia Holdings |
| EV/EBITDA | 24.14 | 15.42 | Iqvia Holdings |
| Profit Margin (TTM) | 29.34% | 7.88% | Illumina |
| Operating Margin (TTM) | 18.79% | 13.39% | Illumina |
| EBITDA Margin (TTM) | 18.79% | 13.39% | Illumina |
| Return on Equity | 68.06% | 19.79% | Illumina |
| Return on Assets (TTM) | 4.25% | 5.16% | Iqvia Holdings |
| Free Cash Flow (TTM) | $709.00M | $2.11B | Iqvia Holdings |
| 1-Year Return | -22.52% | -23.21% | Illumina |
| Price-to-Sales Ratio (TTM) | 3.67 | 2.07 | Iqvia Holdings |
| Enterprise Value | $16.70B | $45.08B | Iqvia Holdings |
| EV/Revenue Ratio | 3.90 | 2.87 | Iqvia Holdings |
| Gross Profit Margin (TTM) | 65.63% | 32.94% | Illumina |
| Revenue per Share (TTM) | $27 | $89 | Iqvia Holdings |
| Earnings per Share (Diluted) | $7.90 | $6.90 | Illumina |
| Beta (Stock Volatility) | 1.37 | 1.30 | Iqvia Holdings |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Illumina vs Iqvia Holdings Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Illumina | 2.53% | 1.69% | -0.23% | 26.40% | 8.34% | -22.25% |
| Iqvia Holdings | 3.11% | 0.03% | 2.01% | 38.47% | -1.85% | -2.03% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Illumina | -22.52% | -49.04% | -70.44% | -48.12% | 131.21% | 1,588.23% |
| Iqvia Holdings | -23.21% | -12.98% | 18.56% | 154.05% | 350.93% | 350.93% |
Performance & Financial Health Analysis: Illumina vs Iqvia Holdings
| Metric | ILMN | IQV |
|---|---|---|
| Market Information | ||
| Market Cap | $15.72B | $32.50B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 1,378,370 | 1,217,482 |
| 90 Day Avg. Volume | 2,018,857 | 1,996,797 |
| Last Close | $101.80 | $191.15 |
| 52 Week Range | $68.70 - $156.66 | $134.65 - $252.88 |
| % from 52W High | -35.02% | -24.41% |
| All-Time High | $540.63 (Feb 08, 2021) | $285.61 (Dec 27, 2021) |
| % from All-Time High | -81.17% | -33.07% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.05% | 0.05% |
| Quarterly Earnings Growth | -0.05% | -0.27% |
| Financial Health | ||
| Profit Margin (TTM) | 0.29% | 0.08% |
| Operating Margin (TTM) | 0.19% | 0.13% |
| Return on Equity (TTM) | 0.68% | 0.20% |
| Debt to Equity (MRQ) | 115.06 | 272.12 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $14.66 | $33.99 |
| Cash per Share (MRQ) | $7.52 | $12.87 |
| Operating Cash Flow (TTM) | $1.15B | $2.62B |
| Levered Free Cash Flow (TTM) | $111.38M | $2.45B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Illumina vs Iqvia Holdings
| Metric | ILMN | IQV |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 12.57 | 27.70 |
| Forward P/E | 22.46 | 15.84 |
| PEG Ratio | -0.11 | -1.25 |
| Price to Sales (TTM) | 3.67 | 2.07 |
| Price to Book (MRQ) | 6.77 | 5.62 |
| Market Capitalization | ||
| Market Capitalization | $15.72B | $32.50B |
| Enterprise Value | $16.70B | $45.08B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.90 | 2.87 |
| Enterprise to EBITDA | 24.14 | 15.42 |
| Risk & Other Metrics | ||
| Beta | 1.37 | 1.30 |
| Book Value per Share (MRQ) | $14.66 | $33.99 |
Financial Statements Comparison: Illumina vs Iqvia Holdings
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ILMN | IQV |
|---|---|---|
| Revenue/Sales | $1.04B | $3.83B |
| Cost of Goods Sold | $358.00M | $2.53B |
| Gross Profit | $683.00M | $1.30B |
| Research & Development | $252.00M | N/A |
| Operating Income (EBIT) | $164.00M | $525.00M |
| EBITDA | $276.00M | $786.00M |
| Pre-Tax Income | $182.00M | $323.00M |
| Income Tax | $51.00M | $61.00M |
| Net Income (Profit) | $131.00M | $249.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ILMN | IQV |
|---|---|---|
| Cash & Equivalents | $1.11B | $1.74B |
| Total Current Assets | $2.67B | $5.91B |
| Total Current Liabilities | $1.44B | $7.18B |
| Long-Term Debt | $2.03B | $13.29B |
| Total Shareholders Equity | $2.37B | $5.99B |
| Retained Earnings | $-1.11B | $6.31B |
| Property, Plant & Equipment | $1.19B | $768.00M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ILMN | IQV |
|---|---|---|
| Operating Cash Flow | $322.00M | $554.00M |
| Capital Expenditures | $-32.00M | $-142.00M |
| Free Cash Flow | $201.00M | $426.00M |
| Debt Repayment | N/A | $-2.10B |
| Common Stock Repurchase | $-200.00M | $-375.00M |
Short Interest & Institutional Ownership Analysis
| Metric | ILMN | IQV |
|---|---|---|
| Shares Short | 7.73M | 6.80M |
| Short Ratio | 3.43 | 2.96 |
| Short % of Float | 0.07% | 0.05% |
| Average Daily Volume (10 Day) | 1,378,370 | 1,217,482 |
| Average Daily Volume (90 Day) | 2,018,857 | 1,996,797 |
| Shares Outstanding | 159.00M | 176.10M |
| Float Shares | 149.35M | 161.46M |
| % Held by Insiders | 0.00% | 0.01% |
| % Held by Institutions | 1.03% | 1.02% |
Dividend Analysis & Yield Comparison: Illumina vs Iqvia Holdings
| Metric | ILMN | IQV |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |